Board of Directors

Erik Nerpin

Chairman

Born in 1961. Lawyer. Self-employed with Advokatfirman Nerpin AB. Independent of the Company and its principal owners. Chairman since March 2015, Board member since 2012. Other assignments include: Chairman of Kancera AB and WYA Holding AB. Board member of Niccocino Holding, Karessa Pharma Holding, Klaria Pharma Holding and Effnetplattformen AB.

Holdings in Diamyd Medical as of August 31, 2015: 15 400 B shares.

Anders Essen-Möller

Board Member and CEO

Born in 1941. M.Sc. CEO since 2015. Founder of and CEO during 1996-2007 of former Diamyd Medical and Chairman 2007-2013. Chairman of present Diamyd Medical 2013 – March 2015. Founder of Synectics Medical AB, sold to Medtronic, Inc. in 1996. Board member of the associated company Cellaviva AB.

Holdings in Diamyd Medical as of August 31, 2015: 958 584 A shares, 3 653 255 B shares.

Maria-Teresa Essen-Möller

Board Member

Born in 1970. M.Sc. in Business Administration. Board member since 2013. Board member of former Diamyd Medical during 2009-2013. Head of Investor Relations and Corporate Communications in former Diamyd Medical during 1997-1999. Account Director at Creuna 2011-2014. Digital Marketing Manager at Sanofi.

Holdings in Diamyd Medical as of August 31, 2015: 24 000 B shares.

Fredrik Åhlander

Board Member

Born in 1973. MD and biologist with degrees from Lund University. Independent of the Company and its principal owners. Board member since 2014. Fredrik Åhlander works as a physician and conducts clinical research. Board member of Pharmiva AB.

Holdings in Diamyd Medical as of August 31, 2015: 0

Management

Anders Essen-Möller

CEO and Board Member

Born in 1941. M.Sc. CEO since 2015. Founder of and CEO during 1996-2007 of former Diamyd Medical and Chairman 2007-2013. Chairman of present Diamyd Medical 2013 – March 2015. Founder of Synectics Medical AB, sold to Medtronic, Inc. in 1996. Board member of the associated company Cellaviva AB.

Holdings in Diamyd Medical as of August 31, 2015: 958 584 A shares, 3 653 255 B shares.

Erika Hillborg

Senior Director Clinical Development

Born in 1967. M.Sc. in Biomedicine from the Karolinska Institute in Stockholm, with a Science Journalism degree from Uppsala University. Joined Diamyd Medical in 2006. Board member of Bullerbyn Parents Association for children with type 1 diabetes.

Holdings in Diamyd Medical as of August 31, 2015: 6 000 B shares.

Anna Styrud

Chief Financial Officer

Born in 1961. B.Sc. in Business Administration from Uppsala University. Prior experience includes Treasurer of Vasakronan AB and various positions in finance and control at Fläkt AB and National Board of Public Building. Joined Diamyd Medical in 2010. Board member of the associated company Cellaviva AB.

Holdings in Diamyd Medical as of August 31, 2015: 30 000 B shares.